From local ballots to Capitol Hill, 2024 is shaping up to see another drug policy reform push that again puts laws around marijuana and psychedelics in the spotlight as advocates work to leverage continuing momentum.
While there will be significant attention on presidential politics in the lead-up to the November election, the stage is already set to advance cannabis and psychedelics reforms, both through the ballot and in legislatures across the country.
Marijuana legalization for medical or recreational use is in play in at least a half dozen states for 2024, and activists will also be pushing to end the criminalization of etheogenic substances like psilocybin, while paving a pathway for regulated access.
At the same time, efforts to pass a bipartisan marijuana banking bill will again rear up next year, and advocates are hopeful that the Drug Enforcement Administration (DEA) will complete its review into cannabis scheduling following a U.S. Department of Health and Human Services (HHS) recommendation to move it to Schedule III under the Controlled Substances Act (CSA).
Meanwhile, the stage is set for Germany to become the largest country in Europe to legalize cannabis in 2024.
Nothing is guaranteed—but with public sentiment increasingly favoring reform and
Read full article on Marijuana Moment
